Effects of histamine on Th1/Th2 cytokine balance

International Immunopharmacology

Volumn 3, Issue 7, 2003, Pages 909-920

  Packard, Kathleen A ^a   Khan, Manzoor M ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Asthma; Histamine; Th1 Th2

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; JANUS KINASE; LEUKOTRIENE; LEUKOTRIENE DERIVATIVE; METHYLXANTHINE; NEDOCROMIL; NITRIC OXIDE; PROSTAGLANDIN E2; RANITIDINE; TERFENADINE;

ALLERGIC ASTHMA; CELL FUNCTION; CYTOKINE RELEASE; DRUG EFFECT; GENETIC TRANSCRIPTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFECTION PREVENTION; MAST CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

EID: 0038459267     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00235-7     Document Type: Review

References (86)

1. NHLBI, National Asthma Education Program, Expert Panel Report. Guidelines for the diagnosis and management of asthma. Publication No. 97-4051. Bethesda, MD, U.S. Department of Health and Human Services; 1997.
2. Kent T.H., Hart M.N. Asthma. Introduction to human disease. 1993;227 Appleton & Lange, Norwalk, CT.
3. American Lung Association Website, Trends in asthma morbidity and mortality, 2001. www.lungusa.org/data/asthma/asthmach_cha.html.
4. National Institute of Environmental Health Sciences. Fact Sheet #9; July, 1997.
5. Babe K.S., Serafin W.E. Histamine, bradykinin, and their antagonists. Goodman and Gilman's the pharmacological basis of therapeutics. 1996;581-593 McGraw-Hill, New York.
6. Liu C., Wilson S.J., Kuei C., Lovenberg T.W. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacologic species variation. J. Pharmacol. Exp. Ther. 299(1):2001;121-130.
7. Oda T., Matsumoto S. Identification and characterization of histamine H4 receptor. Nippon Yakurigaku Zasshi. 118(1):2001;36-42.
8. Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R.et al. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. 59(3):2001;427-433.
9. Elenkov I., Webster E., Papanicolaou D.A., Fleisher T.A., Chrousos G.P., Wilder R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161:1998;2583-2593.
10. Khan M.M., Melmon K.L. Selected autacoids as modulators of lymphocyte function. Handbook of experimental pharmacology. vol. 85:1988;363-383 Springer-Verlag, Berlin.
11. Khan M.M., Sansoni P., Engleman E.G., Melmon K.L. Pharmacologic effects of autacoids on subsets of T cells. J. Clin. Invest. 75:1985;1578-1583.
12. Khan M.M., Melmon K.L. Are autocoids more than theoretic modulators of immunity? Clin. Immunol. Rev. 4:1985;1-30.
13. Khan M.M., Keaney K.M., Melmon K.L., Clayberger C., Krensky A.M. Histamine regulates the generation of human cytolytic T lymphocytes. Cell. Immunol. 121:1989;60-73.
14. Khan M.M., Melmon K.L., Fathman C.G., Hertel-Wulff B., Strober S. The effects of autocoids on cloned murine lymphoid cells: modulation of IL-2 secretion and the activity of natural suppressor cells. J. Immunol. 134:1985;4100-4106.
15. Sansoni P., Silverman E.D., Khan M.M., Melmon K.L., Engleman E.Q. Immunoregulatory T cells in man. J. Clin. Invest. 75:1985;650-656.
16. Khan M.M., Marr-Leisy D., Verlander M.S., Bristow M.R., Strober S., Goodman M.et al. The effects of derivatives of histamine on natural suppressor cells. J. Immunol. 137:1986;308-314.
17. Weltman J.K. Update on histamine as a mediator of inflammation. Allergy Asthma Proc. (3):2000 (May-Jun);125-128.
18. Carlsson R., Dohlsten M., Sjogren H.O. Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells. Cell. Immunol. 96(1):1985;104-112.
19. Dohlsten M., Sjogren H.O., Carlsson R. Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesis. Cell. Immunol. 101(2):1986;493-501.
20. Arad G., Nussinovich R., Na'amad M., Kaempfer R. Dual control of human interleukin-2 and interferon-gamma gene expression by histamine: activation and suppression. Cell. Immunol. 170:1996;149-155.
21. Krouwels F.H., Hol B.E.A., Lutter R., Bruinier B., Bast A. Histamine affects interleukin-4, interleukin-5, and interferon-gamma by T cell clones from the airways and blood. Am. J. Respir. Cell Mol. Biol. 18(5):1998;721-730.
22. Schmidt J., Fleissner S., Heimann-Weitschat I., Lindstaedt R., Szelenyi I. Histamine increases anti-CD3 induced IL-5 production of Th2-type T cells via histamine H2-receptors. Agents Actions. 42:1994;81-85.
23. Poluektova L.Y., Khan M.M. Protein kinase A inhibitors reverse histamine-mediated regulation of IL-5 secretion. Immunopharmacology. 39:1998;9-19.
24. Osna N., Elliott K., Khan M.M. The effects of histamine on interferon gamma production are dependent on the stimulatory signals. Int. Immunopharmacol. 1:2001;125-145.
25. Osna N., Elliott K., Khan M.M. Regulation of interleukin-10 secretion by histamine in Th2 cells and splenocytes. Int. Immunopharmacol. 1:2001;85-86.
26. Elliott K., Osna N., Scofield M., Khan M.M. Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. Int. Immunopharmacol. 1:2001;1923-1937.
27. Sirois J., Menard G., Moses A.S., Bissonnette E.Y. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J. Immunol. 164:2000;2964-2970.
28. Poluektova L.Y., Huggler G.K., Patterson E.B., Khan M.M. Involvement of protein kinase A in histamine-mediated inhibition of IL-2 mRNA expression in mouse splenocytes. Immunopharmacology. 41(2):1999;77-87.
29. Levy F., Kristofic C., Heuser C., Brinkman V. Role of IL-13 in CD4 T cell dependent IgE production in atopy. Int. Arch. Allergy Immunol. 112:1997;49-58.
30. De Vries J.E., Zurawski G. Immunoregulatory properties of IL-13: its potential role in atopic disease. Int. Arch. Allergy Immunol. 106:1995;175-179.
31. Defrance T., Carayon P., Billian G., Guillemot J.C., Minty A., Caput D.et al. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179:1994;135-143.
32. Punnonen J., Aversa G., Cocks B.G., McKenzie A.N.J., Menon S., Zurawski G.et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. 90:1993;3730-3734.
33. Snijdewint F.G.M., Kalinski P., Wierenga E.A., Bos J.D., Kapsenberg M.L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:1993;5321-5329.
34. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not Th2 lymphokines. J. Immunol. 146:1991;108-113.
35. Goodwin J.S., Ceuppens J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 3:1983;295-315.
36. Goodwin J.S., Bankhurst A.D., Messner R.P. Suppression of human T-cell mitogenesis by prostaglandin. J. Exp. Med. 146:1977;1719-1734.
37. Goto T., Herberman R.B., Maluish A., Strong D.M. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J. Immunol. 130:1983;1350-1355.
38. Benbernou N., Esnault S., Shin H.C.K., Fekkar H., Guenounou M. Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology. 91:1997;361-368.
39. Liew F.Y., Li Y., Severn A., Millott S., Schmidt J., Salter M.et al. A possible novel pathway of regulation by murine T helper type-2 cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21(10):1991;2489-2494.
40. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P.et al. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24(4):1994;980-984.
41. Brune M., Hansson M., Mellqvist U.H., Hermodsson S., Hellstrand K. NK-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites. Eur. J. Haematol. 57(4):1996;312-319.
42. Lagier B., Lebel B., Bousquet J., Pene J. Different modulation by histamine of IL-4 and interferon-gamma release according to the phenotype of human Th0, Th1 and Th2 clones. Clin. Exp. Immunol. 108(3):1997;545-551.
43. Lohmann S.M., Walter U. Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. Adv. Cycl. Nucleotide Protein Phosphoryl. Res. 18:1984;63-117.
44. Kammer G.M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today. 9(7-8):1988;222-229.
45. Shin H.C.K., Benbernou N., Esnault S., Guenonou M. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine. 11(4):1999;257-266.
46. Teschendorf C., Trenn G., Hoffkes H.G., Brittinger G. Differential regulation of the activation of protein kinase A on the protein synthesis and secretion in the T-helper 2 cell line D10.G4.1. Scand. J. Immunol. 44:1996;150-156.
47. Siegmund B., Eigler A., Hartmann G., Hacker U., Endres S. Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway. Int. J. Immunopharmacol. 20:1998;57-69.
48. Eigler A., Siegmund B., Emmerich U., Baumann K.H., Hartmann G., Endres S. Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J. Leukoc. Biol. 63:1998;101-107.
49. Till S., Durham S., Dickason R., Huston D., Bungre J., Walker S.et al. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-γ secretion. Immunology. 91:1997;53-57.
50. Schmidt-Weber C.B., Alexander S.I., Henault L.E., James L., Lichtman A.H. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J. Immunol. 162:1999;238-244.
51. Essayan D.M., Krishnaswamy G., Oriente A., Lichtenstein L.M., Huang S.K. Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-γ J. Allergy Clin. Immunol. 103:1999;451-457.
52. Li Y., Simons E.R., HayGlass K.T. Environmental antigen-induced IL-13 responses are elevated among subjects with allergic rhinitis, are independent of IL-4 and are inhibited by endogenous IFN-γsynthesis. J. Immunol. 161:1998;7007-7014.
53. Girdlestone J., Wing M. Autocrine activation by interferon-gamma of STAT factors following T cell activation. Eur. J. Immunol. 26(3):1996;704-709.
54. Ranshoff R.M. Cellular responses to interferons and other cytokines: the JAK-STAT paradigm. N. Engl. J. Med. 338(9):1998;616-618.
55. Haque S.J., Williams B.R. Signal transduction in the interferon system. Semin. Oncol. 25(1 Suppl. 1):1998;14-22.
56. Ohmori Y., Hamilton T.A. IL-4 induced STAT6 suppresses IFNγ-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol. 159:1997;5474-5482.
57. Moriggl R., Kristofic C., Kinzel B., Volarevic S., Groner B., Brinkman V. Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4. J. Immunol. 160(7):1998;3385-3392.
58. Kirken R.A., Erwin R.A., Taub D., Murphy W.J., Behbod F., Wang L.et al. Tyrphostin AG-490 inhibits cytokine-mediated Jak3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells. J. Leukoc. Biol. 65:1999;891-898.
59. Nielsen M., Kaltoft K., Nordahl M., Ropke C., Geisler C., Mustelin T.et al. Constitutive activation of a slowly migration isoform of STAT3 in mycosis fungoides: tyrphostin AG490 inhibits STAT3 activation and growth of mucosis fungoides tumor cell lines. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6764-6769.
60. Wang L.H., Kirken R.A., Erwin R.A., Yu C.R., Farrar W.L. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG 490 regulation of IL-2-mediated T cell response. J. Immunol. 162:1999;3897-3904.
61. Osna N., Elliott K., Chaiko O., Patterson E., Lewis R.E., Khan M.M. Histamine utilizes Jak-STAT pathway in regulating cytokine production. Int. Immunopharmacol. 1:2001;759-762.
62. Kuo M.L., Huang J.L., Yeh K.W., Li P.S., Hsieh K.H. Evaluation of Th1/Th2 ratio and cytokine production profile during acute exacerbation and convalescence in asthmatic children. Ann. Allergy Asthma Immunol. 86(3):2001;272-276.
63. Wills-Karp M. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 107(1):2001;9-18.
64. Spinozzi F., Agea E., Russano A., Bistoni O., Minelli L., Bologni D.et al. CD4+IL13+T lymphocytes at birth and the development of wheezing and/or asthma during the 1st year of life. Int. Arch. Allergy Immunol. 124:2001;497-501.
65. Knol K. Clinical use of antihistamines in infants and children at risk of asthma development. Allergy. 55:2000;31-34.
66. Munakata Y., Umezawa Y., Iwata S., Dong R.P., Yoshida S., Ishii T.et al. Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro. Clin. Exp. Allergy. 29:1999;1281-1286.
67. Testa B., Mesolella C., Mosti M.R., Mesolella M., Testa D., Motta G. Changes in serum interferon-γ, interleukin-4, and interleukin-12 cytokine levels in anti-histamine type 2-treated allergic rhinitis patients. Laryngoscope. 111:2001;236-239.
68. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Pediatr. Allergy Immunol. 9:1998;116-124.
69. Nakajima H., Iwamoto I., Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am. Rev. Respir. Dis. 148:1993;1102-1104.
70. Lack G., Bradley K.L., Manelmann E., Renz H., Loader J., Leung D.Y.et al. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J. Immunol. 157(4):1996;1432-1439.
71. Boguniewicz M., Schneider L.C., Milgrom H., Newell D., Kelly N., Tam P.et al. Treatment of steroid-dependent asthma with recombinant interferon-gamma. Clin. Exp. Allergy. 23(9):1993;785-790.
72. Caron G., Delneste Y., Roelandts E., Duez C., Bonnefoy J.Y., Pestel J.et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 167(7):2001;3682-3686.
73. Schwarze M.J., Hamelmann E., Cieslewica G., Tomkinson A., Joetham A., Bradley K.et al. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allergy Clin. Immunol. 102(1):1998;86-93.
74. Tourney K.G., Kips J.C., Pauwels R.A. Counterbalancing of TH2-driven allergic airway inflammation by IL-12 does not require IL-10. J. Allergy Clin. Immunol. 107(3):2001;483-491.
75. Kips J.C., Brusselle G.J., Joos G.F., Peleman R.A., Tavernier J.H., Devos R.R.et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153(2):1996;535-539.
76. Brusselle G.G., Kips J.C., Tavernier J.H., van der Heyden J.G., Cuvelier C.A., Pauwels R.A.et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy. 24:1994;73-80.
77. Borish L.C., Nelson H.S., Corren J., Bensch G., Busse W.W., Whitmore J.B.et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J. Allergy Clin. Immunol. 107(6):2001;63-970.
78. Stirling R.G., Chung K.F. New immunological approaches and cytokine targets in asthma and allergy. Eur. Respir. J. 16:2000;1158-1174.
79. Pauwels R.A., Brusselle G.G., Tournoy K.G., Lambrecht B.N., Kips J.C. Cytokines and their receptors as therapeutic targets in asthma. Clin. Exp. Allergy. 28:1998;1-5.
80. Ramshaw H., Woodcock J., Bagley C., McClure B., Hercus T., Lopez A. New approaches in the treatment of asthma. Immunol. Cell Biol. 79(2):2001;154-159.
81. Walker C. Cytokine inhibitor strategies. Pulm. Pharmacol. Ther. 12:1999;73-77.
82. Tourney K.G., Kips J.C., Pauwels R.A. Absence of interleukin-10 aggravates airway inflammation in mice. Am. J. Respir. Crit. Care Med. 157:1998;A701.
83. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M.et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:1998;2261-2262.
84. Oshima Y., Puri R.K. Characterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13. J. Biol. Chem. 276(18):2001;11585-11591.
85. Kato Y., Manabe T., Tanaka Y., Mochizuki H. Effect of an orally active Th2/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. J. Immunol. 162(12):1999;7470-7479.
86. Poluektova L.Y., Khan M.M. Protein kinase A inhibitors reverse histamine-mediated regulation of IL-5 secretion. Immunopharmacology. 39:1998;9-19.